Safety Study of GSK1995057 Given as Single and Repeat Intravenous Doses in Healthy Subjects.

NCT01476046 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Respiratory Disorders

Interventions

DRUG: GSK1995057 single dose
DRUG: Placebo

Sponsor

GlaxoSmithKline